PODD

Insulet Corporation Press Releases

$44.83
*  
2.35
5.53%
Get PODD Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading PODD now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PODD Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Insulet Corporation to Present at Upcoming Investor Conferences
11/24/2014 4:15:00 PM - Market Wire


Insulet Corporation Appoints New Chief Financial Officer and Executive Vice President, Human Resources
11/5/2014 4:07:00 PM - Market Wire
▲11.32 % Price Change since this news event. The Volume Ratio is 2.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Insulet Reports Third Quarter 2014 Results
11/5/2014 4:05:00 PM - Market Wire
▲11.32 % Price Change since this news event. The Volume Ratio is 2.85.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Insulet Corporation to Present at Upcoming Investor Conferences
11/3/2014 4:15:00 PM - Market Wire
▲7.38 % Price Change since this news event. The Volume Ratio is 2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Insulet Corporation to Report Third Quarter 2014 Financial Results on November 5, 2014
10/21/2014 4:15:00 PM - Market Wire
▲16.35 % Price Change since this news event. The Volume Ratio is 0.46.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Capricor Therapeutics Announces Plans to Pursue a Cenderitide Clinical Program and Enters Into Research Support Agreement With Insulet Corporation
10/9/2014 8:22:00 AM - GlobeNewswire